These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

967 related items for PubMed ID: 19690229

  • 1. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
    ten Berg MJ, van den Bemt PM, Huisman A, Schobben AF, Egberts TC, van Solinge WW.
    Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
    [Abstract] [Full Text] [Related]

  • 2. A benchmark for platelet count monitoring with low-molecular-weight heparin: expanding implementation of National Patient Safety Goals.
    Spinler SA.
    Ann Pharmacother; 2009 Sep; 43(9):1519-21. PubMed ID: 19690223
    [Abstract] [Full Text] [Related]

  • 3. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
    Wester JP, Leyte A, Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Haak EA, Porcelijn L, Zandstra DF.
    Neth J Med; 2007 Mar; 65(3):101-8. PubMed ID: 17387236
    [Abstract] [Full Text] [Related]

  • 4. The management of heparin-induced thrombocytopenia.
    Keeling D, Davidson S, Watson H, Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative Analysis of the Suspected Heparin-Induced Thrombocytopenia Level in Korea.
    Kim HS, Kim H, Jeong YJ, Lee H, Yim HW, Kim JI, Moon IS, Kim JY.
    Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):360-367. PubMed ID: 28374942
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia.
    Welsby IJ, Um J, Milano CA, Ortel TL, Arepally G.
    Anesth Analg; 2010 Jan 01; 110(1):30-5. PubMed ID: 19933539
    [Abstract] [Full Text] [Related]

  • 9. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG.
    Eur J Med Res; 2004 Apr 30; 9(4):225-39. PubMed ID: 15210403
    [Abstract] [Full Text] [Related]

  • 10. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H, Gunzenhauser D, Sawitzki H, Fung S, Janssen D.
    Z Kardiol; 2003 Jul 30; 92(7):532-9. PubMed ID: 12883837
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.
    Ban-Hoefen M, Francis C.
    Thromb Res; 2009 Jun 30; 124(2):189-92. PubMed ID: 19195684
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Heparin-induced thrombocytopenia: recent experience in a large teaching hospital.
    Sturtevant JM, Pillans PI, Mackenzie F, Gibbs HH.
    Intern Med J; 2006 Jul 30; 36(7):431-6. PubMed ID: 16780449
    [Abstract] [Full Text] [Related]

  • 16. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A, Alban S, Omer-Adam MA, Weitschies W, Warkentin TE.
    Thromb Res; 2008 Jul 30; 122(2):211-20. PubMed ID: 18262226
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A cohort study investigating compliance with guidelines for platelet count monitoring during heparin thromboprophylaxis.
    Kim S, Trick WE.
    Hosp Pract (1995); 2012 Apr 30; 40(2):88-95. PubMed ID: 22615083
    [Abstract] [Full Text] [Related]

  • 19. Heparin-induced thrombocytopenia in medical surgical critical illness.
    Warkentin TE, Sheppard JI, Heels-Ansdell D, Marshall JC, McIntyre L, Rocha MG, Mehta S, Davies AR, Bersten AD, Crozier TM, Ernest D, Vlahakis NE, Hall RI, Wood GG, Poirier G, Crowther MA, Cook DJ, Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group.
    Chest; 2013 Sep 30; 144(3):848-858. PubMed ID: 23722881
    [Abstract] [Full Text] [Related]

  • 20. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
    Schroder JN, Daneshmand MA, Villamizar NR, Petersen RP, Blue LJ, Welsby IJ, Lodge AJ, Ortel TL, Rogers JG, Milano CA.
    Ann Thorac Surg; 2007 Sep 30; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.